Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Drug Alcohol Depend. 2013 Aug 13;132(0 1):S56–S60. doi: 10.1016/j.drugalcdep.2013.07.017

Table 1.

The prevalence of HIV and Overdose among PWID in Central Asia and Status of Naloxone

Country Estimated
# of
IDUS1
HIV
Prevalence1
Non-Fatal
Opioid OD
Prevalence
Mortality
Rate from
Overdose
Deaths
Naloxone
Status
Naloxone Distribution Data
Kazakhstan 186,000 3.98% –
28%2
20% of
PWID in
past year3,4
2.1% (11
deaths)
found
over a 1-
year
period
among
480
PWID3
Registered,
but not
included in
MOH
purchase
list since
2011
Pilot naloxone distribution projects in
NGOs in Almaty and Karaganda have
distributed naloxone to a total of 388
PWID and 97 PWID have reported
successfully reversing an opioid
overdose.3, 8 These pilots were
interrupted from September 2011 until
January 2013 when naloxone was not
included on the MOH purchase list.
Kyrgyzstan 44,000 11% 40% life
time
prevalence
5i
Not
Available
(N/A)
Registered
and
purchased
by global
fund
Narcology dispensaries around the
country have distributed naloxone kits to
2200 PWID since November 2012. To
date, NGOs have reported 22 cases
where naloxone was successfully used8.
Tajikistan 34,000 23.6% 23.6% of
PWID in
past year6
N/A Registered
and
purchased
by global
fund
Tajikistan NGOs distributed a total of
1,836 ampoules of naloxone to PWID
clients since 2011. To date, 108 cases
were reported where naloxone was used
to successfully reverse an OD8
Turkmenistan 11,148 N/A N/A N/A N/A --
Uzbekistan 80,000 15.3% N/A 0.13 per
100,0007
Registered
but not
included in
purchase
list
--
Total 247,0009
355,14810
11% N/A N/A -- --
1

UNODC. (2010). Accessibility of HIV Prevention, Treatment and Care Services for People who use Drugs and Incarcerated People in Azerbaijan, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan.. Ashgabat, Turkmenistan.

2

El-Bassel, N., Gilbert, L., Terlikbayeva, A., Wu, E., Beyrer, C., Shaw, S., et al. (in press). HIV among Injection Drug Users and their Intimate Partners in Almaty, Kazakhstan. AIDS & Behavior.

3

Gilbert, L., El-Bassel, N., Primbetova, S., Hunt, T., Terlikbayeva, A., & Chang, M. (2012). Co-occurring Opioid Overdose and HIV risks among PWID in Kazakhstan: Findings from Project Renaissance. Paper presented at the National Treatment as Prevention Conference.

4

Kazakhstan RAC. (2010). Results of a Behavioral Surveillance Survey. Republican AIDS Center of Kazakhstan. Almaty, Kazakhstan.

5

Republican Narcological Center. (2012). Results of a Behavioral Surveillance Survey. Republican Narcological Center. Bishkek, Kyrgyzstan.

6

Tajikistan RAC. (2011). Results of Behavioral Surveillance Survey. Tajikstan Republican AIDS Center. Dushanbe, Tajikstan.

7

The National Centre on Drug Control. (2012). 2012 National Report on the Drug Situation in the Republic of Uzbekistan. CADAP. Tashkent, Uzbekistan.

8

Primbetova, S., El-Bassel, N., Gilbert, L., Terlikbayeva, A., & Hunt, T. (2012). Use of DatStat sofware for data collection, monitoring, and evaluation of naloxone peer distribution programs to respond to opioid overdoses among people living with HIV and injecting drug users in Central Asia. Paper presented at the XIX International AIDS Conference.

9

Degenhardt, l. 2012. Extent of Illicit Drug Use and Dependence, and their Contribution to the Global Burden of Disease. Lancet, 379, 55–70.

10

The estimate of 355,148 represents the sum of the estimates of PWID of all five countries listed above.